Finance

NewTimeSpace News: On 28 August 2026, BAIYUNSHAN PH (00874.HK) announced that subsidiary Guangzhou Pharmaceutical had signed a delivery confirmation letter with Xingzheng Asset Management to sell accounts receivable with a book value of RMB 149 million, receiving a purchase price of RMB 146,322,872.24; aggregated with past transactions within 12 months, the percentage ratio exceeds 5% but is below 25%, constituting a discloseable transaction not requiring shareholder approval.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, the three major Hong Kong indices ended mixed, with the Hang Seng Index edging up 0.07% to 25,584.79 points, the Hang Seng TECH Index down 0.33%, and turnover at HKD 231.2 billion. Software stocks advanced, with KINGDEE INT'L up 6.23%; gold stocks led gains, with CHINAGOLDINTL up 7.72%; mainland property developers traded actively, with SUNAC up 10.66%. Storage and semiconductor technology names led declines, with VGT down 12.96%; large-model concepts were weak, with Z.AI down over 6% and MINIMAX down over 4%. Southbound capital recorded net buying of HKD 1.176 billion. TIANQI LITHIUM's interim net profit surged 4,925%, GUSHENGTANG's interim profit rose 45.5%, and DIAGENS-B has met the criteria for Stock Connect inclusion.

NewTimeSpace · 2026-08-28

On August 28, 2026, Hong Kong's three major indices closed mixed, with AI concept stocks diverging on the day and most large-model and AI chip sectors weakening. The Hang Seng Index rose 0.07%, the Hang Seng TECH Index fell 0.33%, and the Hang Seng China Enterprises Index closed flat.In the embodied-AI segment, UBTECH ROBOTICS (09880.HK) closed up 0.66%, XIAOMI-W (01810.HK) rose 1.24%.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, BUSYMING (01768.HK) issued an inside information announcement stating that it had applied to the CSRC to convert 1,536,088 domestic unlisted shares (par value RMB 1.00 each) held by director Mr. Wang Yutong, representing approximately 0.71% of the total issued share capital, into H shares for listing and trading on the Main Board, in a plan to implement the full circulation of H shares; the CSRC filing procedures have not yet been completed.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, CSPC PHARMA (01093.HK) announced that the Phase II clinical trial (SYH2069-004) of SYH2069 Injection for weight management in overweight or obese adult patients had been officially launched at the first study site in China; the product is a GLP-1R/GIPR dual-target dual-biased agonist that obtained the NMPA Drug Clinical Trial Approval Notice in December 2025.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, SBP GROUP (01177.HK) announced that LM-364 "Nectin-4ᵀᴹᴱ ADC", a national Class 1 innovative drug independently developed by wholly-owned subsidiary LaNova Medicines, had obtained implied clinical trial approval from China's NMPA for advanced solid tumors, after receiving FDA approval and initiating clinical trials in Australia in April this year; preclinical data disclosed at the 2026 AACR Annual Meeting showed TGI of up to 168.79% across PDX models.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, HK.AI CAPITAL (01140.HK) announced the appointment of Mr. Tsang Sze Wai as an executive director with effect from 28 August 2026, entitled to a director's fee of HKD 720,000 per annum; Mr. Tsang, aged 49, is a CFA charterholder and former Templeton Asset Management executive who has served as chief executive officer and chairman of multiple Nasdaq-listed SPACs.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, WEI YUAN HLDG (01343.HK) announced that WGC, its indirect wholly-owned subsidiary, has accepted the JTC consent letter to proceed with the redevelopment of the property in Singapore, raising the aggregate plot ratio from 0.85 and 0.90 to 1.40 on a combined basis, with completion required within two years from the date of the consent letter; the redevelopment may constitute a discloseable transaction under Chapter 14 of the Listing Rules.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, FRIENDTIMES (06820.HK) announced that Warm Sunshine, held by controlling shareholder Mr. Jiang Xiaohuang, purchased 1,600,000 shares on the open market on 26 August 2026, representing approximately 0.07% of the total issued share capital; following the purchase, Mr. Jiang's interest increased to 1,254,108,157 shares, representing approximately 57.51% of the total issued share capital.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, SIWI SCI & TECH (01202.HK) announced the lapse and termination of the possible very substantial disposal of its entire interest in Putian New Materials via public listing, as no bids were received during the initial and extended listing periods, with no material adverse impact expected.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 31 August 2026, CHK OIL (00632.HK) announced that Mr. Jin Ailong has been re-designated from CEO to CEO (China Business), Mr. Lam Pui Wang has been appointed CEO (Global Business) and Mr. Huang Songjian has been appointed Chief Risk Officer, all effective from 31 August 2026 while continuing as executive directors; Mr. Jin receives HKD 1,320,000 per annum, while Mr. Lam and Mr. Huang each receive HKD 50,000 per month.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, MOMENTUM FIN (01152.HK) issued a profit warning, expecting an H1 consolidated net loss of approximately HKD 3.2 million, versus a net profit of approximately HKD 3.6 million a year earlier, driven by lower gross profit, higher expenses and higher income tax.

NewTimeSpace · 2026-08-28

NewTimeSpace News: On 28 August 2026, SHANDONG XINHUA (00719.HK) announced that its Dapoxetine Hydrochloride Tablets had obtained the Drug Registration Certificate from the National Medical Products Administration, with approval number Guoyao Zhunzi H20265706, at a specification of 30 mg under Chemical Drug Category 4, following an application filed and accepted in April 2025; dapoxetine sales in Chinese public medical institutions reached approximately RMB 1.03 billion in 2025, and the Company said the product would further enrich its formulation portfolio.

NewTimeSpace · 2026-08-28

NewTimeSpace reported, on August 28, 2026, the Hang Seng Index up 0.07%, the Hang Seng TECH Index down 0.33%, and the Hang Seng China Enterprises Index closing flat. The Hang Seng Index recorded a market-wide turnover of HK$231.209 billion, Southbound funds saw a net inflow of HK$1.176 billion.

NewTimeSpace · 2026-08-28

NewTimeSpace (newtimespace.com) News, on August 26, 2026, the chip theme weakened, with SMIC (688981.SH) fluctuating lower. As of 13:23, the company was quoted at HK$70.850, down 0.63%.

NewTimeSpace · 2026-08-28

NewTimeSpace (newtimespace.com) News, on August 28, 2026, the robotics theme weakened amid volatility, while UBTECH ROBOTICS (09880.HK) rose marginally against the trend. As of 13:11, the company was quoted at HK$83.150, up 0.24%.

NewTimeSpace · 2026-08-28
Previous1..1920 212223..270     270 pages total